HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qin Xu Selected Research

ulipristal

9/2011Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas.
11/2010Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
5/2010Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
3/2008Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
6/2007Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
9/2006Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells.
2/2005Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qin Xu Research Topics

Disease

68Neoplasms (Cancer)
06/2022 - 04/2000
20Squamous Cell Carcinoma of Head and Neck
01/2021 - 11/2003
18Neoplasm Metastasis (Metastasis)
01/2022 - 06/2003
13Alzheimer Disease (Alzheimer's Disease)
01/2021 - 09/2003
13Leiomyoma (Uterine Fibroids)
09/2011 - 02/2005
12Malaria
03/2022 - 01/2016
11Inflammation (Inflammations)
09/2022 - 03/2006
9Infections
03/2022 - 04/2004
7Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 08/2010
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 08/2017
7Carcinoma (Carcinomatosis)
01/2016 - 04/2000
6Carcinogenesis
01/2022 - 08/2010
6Stroke (Strokes)
12/2021 - 08/2006
6Breast Neoplasms (Breast Cancer)
12/2021 - 10/2014
6Mouth Neoplasms (Oral Cancer)
01/2020 - 04/2004
5COVID-19
03/2022 - 10/2020
5Body Weight (Weight, Body)
03/2022 - 06/2002
5Ischemic Stroke
01/2022 - 08/2006
5Falciparum Malaria (Plasmodium falciparum Malaria)
01/2021 - 12/2015
4Weight Loss (Weight Reduction)
01/2021 - 04/2017
3Fibrosis (Cirrhosis)
09/2022 - 04/2008
3Hypertension (High Blood Pressure)
01/2022 - 02/2019
3Transient Ischemic Attack
12/2021 - 09/2021
3Acute Lung Injury
03/2021 - 08/2018
3Hemangioma (Angioma)
01/2021 - 06/2006
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 07/2020
3Diabetes Mellitus
05/2020 - 01/2013
3Glioma (Gliomas)
01/2020 - 07/2015
3Amyloid Plaque
01/2019 - 03/2004
3Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 11/2014
3Obesity
10/2018 - 01/2016
3Hyperthyroidism
01/2016 - 01/2015
3Lymphatic Metastasis
08/2014 - 08/2010
3Menorrhagia
09/2011 - 06/2007
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2005 - 11/2002

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2004
29Pharmaceutical PreparationsIBA
03/2022 - 11/2002
12artemisinin (artemisinine)IBA
03/2022 - 12/2015
10Messenger RNA (mRNA)IBA
01/2022 - 09/2004
10Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2002
10Progesterone Receptors (Progesterone Receptor)IBA
11/2010 - 02/2005
9DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2000
9Biological ProductsIBA
11/2020 - 06/2008
9Apolipoprotein E4IBA
02/2012 - 09/2003
7EnzymesIBA
01/2022 - 04/2008
7piperaquineIBA
01/2021 - 11/2018
7Metalloproteases (Metalloproteinases)IBA
01/2018 - 03/2008
7ulipristalIBA
09/2011 - 02/2005
7ApolipoproteinsIBA
03/2011 - 09/2003
6Glucose (Dextrose)FDA LinkGeneric
09/2022 - 03/2014
6Matrix Metalloproteinases (MMPs)IBA
09/2022 - 03/2008
6CytokinesIBA
03/2022 - 12/2018
6Indicators and Reagents (Reagents)IBA
01/2022 - 04/2004
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 01/2013
6asoprisnilIBA
09/2011 - 04/2006
6ProgesteroneFDA LinkGeneric
11/2010 - 04/2006
5NF-kappa B (NF-kB)IBA
01/2022 - 09/2009
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2004
5RNA (Ribonucleic Acid)IBA
01/2022 - 08/2019
5Long Noncoding RNAIBA
12/2021 - 08/2019
5Peptides (Polypeptides)IBA
11/2021 - 04/2004
5TrichosanthinIBA
11/2021 - 01/2017
5MicroRNAs (MicroRNA)IBA
06/2021 - 03/2013
5Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2010 - 04/2000
4ProdrugsIBA
01/2022 - 01/2017
4Phosphotransferases (Kinase)IBA
12/2021 - 07/2013
4Transcription Factors (Transcription Factor)IBA
12/2021 - 08/2018
4Liposomes (Liposome)IBA
03/2021 - 01/2017
4ORALIT (ORS)IBA
01/2021 - 01/2014
4LigandsIBA
01/2021 - 02/2007
4Complement System Proteins (Complement)IBA
01/2021 - 03/2006
4HMGB1 Protein (HMG1)IBA
12/2019 - 08/2018
4DisintegrinsIBA
01/2018 - 06/2010
4Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2014 - 03/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2010 - 09/2006
4CollagenIBA
11/2010 - 03/2008
4Teniposide (VM 26)FDA Link
06/2005 - 11/2002
3Estrogens (Estrogen)FDA Link
09/2022 - 04/2006
3TabletsIBA
03/2022 - 12/2019
3SodiumIBA
01/2022 - 04/2013
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 08/2009
3Hemoglobins (Hemoglobin)IBA
12/2021 - 08/2017
3Competitive Endogenous RNAIBA
12/2021 - 01/2020
3Antisense OligonucleotidesIBA
12/2021 - 10/2005
3Apolipoproteins E (ApoE)IBA
01/2021 - 03/2004
3LipopolysaccharidesIBA
06/2020 - 03/2018
3Histone Deacetylase InhibitorsIBA
08/2018 - 01/2013
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017 - 06/2005
3Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 11/2002
3Protein Isoforms (Isoforms)IBA
01/2014 - 09/2006
3Caspase 3 (Caspase-3)IBA
10/2013 - 02/2005
3AdrenomedullinIBA
11/2010 - 09/2006
3Epidermal Growth Factor (EGF)IBA
11/2010 - 06/2005

Therapy/Procedure

43Therapeutics
03/2022 - 07/2006
15Drug Therapy (Chemotherapy)
01/2022 - 05/2004
7Immunotherapy
01/2022 - 04/2004
4Lasers (Laser)
01/2021 - 08/2006
4Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2014 - 09/2009
3Bariatric Surgery
01/2020 - 04/2017
2Traditional Medicine (Folk Remedies)
09/2022 - 12/2014